Silviu Popa is a policy and government affairs professional having worked in the biopharmaceutical industry in Brussels for the last 7 years. He currently holds the position of Associate Director for Policy & Government Affairs at Bristol Myers Squibb, supporting Central Eastern Europe, Turkey, Israel and India. Prior to that, he worked at Celgene, first in the EU Government Affairs team between 2015-2018, where he focused particularly on patient access-related policies, including Health Technology Assessment, followed by a role focused on CEE countries and Middle East and Northern Africa. Before joining the pharmaceutical industry, Silviu worked for several years as a political advisor in the European Parliament, mainly to MEP Cristian Busoi from Romania. During this period, a significant part of Silviu’s work focused on healthcare policy and major pieces of EU pharmaceutical legislation, including the last pharmaceutical package, the Clinical Trials Regulation or the Transparency Directive.

Silviu has a good understanding of healthcare and patient access issues in the CEE region and is highly interested in finding ways to accelerate and improve patient access to medical innovation and healthcare in general. Silviu has actively engaged in the EFPIA CEE Task Force for several years and more recently took a leading role in a project focused on healthcare financing in CEE countries.

Silviu grew up in Romania and has a background in political science. He holds a Bachelor’s degree in Social Sciences and a Master’s Degree in European Affairs from Sciences Po Paris.